Morning Overview on MSN
AlphaFold rewired science, and 5 years later it’s still evolving
AlphaFold arrived as a technical moonshot that suddenly made protein structures feel like software rather than secrets of ...
Last month, Demis Hassabis and John Jumper of Google DeepMind were jointly awarded the 2024 Nobel Prize in Chemistry for their development of AlphaFold 3. This AI model can more accurately predict the ...
The DeepMind researchers Demis Hassabis and John Jumper won a share of the Nobel Prize in chemistry. The pair were recognized for their work on protein-structure prediction. In 2020, DeepMind ...
Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More A trio of scientists consisting of Demis Hassabis, co-founder and CEO of ...
Released for free on November 25, The Thinking Game follows the team behind AlphaFold, the Nobel Prize–winning AI ...
In April 2025, Isomorphic Labs raised a $600 million in its first-ever external funding round, led by Thrive Capital. Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed ...
IT IS A recurring joke among chemists that the Nobel prize for chemistry is, more often than not, awarded for developments in biology. Recent examples include awards for the gene-editing tool CRISPR, ...
WIRED spoke with DeepMind’s Pushmeet Kohli about the recent past—and promising future—of the Nobel Prize-winning research project that changed biology and chemistry forever. To understand what the ...
ChatGPT has made generative AI accessible to a wide audience, expanding its applications from text generation to images, sounds and videos. Generative AI’s predictive capabilities are advancing ...
The AI tool AlphaFold has been improved so that it can now predict the shape of very large and complex protein structures. Linköping University researchers have also succeeded in integrating ...
Ivanka Trump congratulates Demis Hassabis on 200M views for his AI documentary. DeepMind's work on AlphaFold system for ...
Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed drugs, its president, Colin Murdoch, told Fortune. Born from DeepMind’s AlphaFold breakthrough, the company is pairing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results